106 related articles for article (PubMed ID: 8800734)
21. Early versus late acute rejection episodes in renal transplantation.
Sijpkens YW; Doxiadis II; Mallat MJ; de Fijter JW; Bruijn JA; Claas FH; Paul LC
Transplantation; 2003 Jan; 75(2):204-8. PubMed ID: 12548124
[TBL] [Abstract][Full Text] [Related]
22. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
[TBL] [Abstract][Full Text] [Related]
23. Amelioration of weight gain after heart transplantation by corticosteroid-free maintenance immunosuppression. UTAH Cardiac Transplant Program.
Hagan ME; Holland CS; Herrick CM; Rasmussen LG
J Heart Transplant; 1990; 9(4):382-4. PubMed ID: 2398433
[TBL] [Abstract][Full Text] [Related]
24. Outcome after steroid withdrawal in heart transplantation.
Castel MA; Vallejos I; Ramos P; Arias A; Bravo C; Ferrero M; Rivero D; Sionis A; Pérez-Villa F; Roig E
Transplant Proc; 2009; 41(6):2253-5. PubMed ID: 19715890
[TBL] [Abstract][Full Text] [Related]
25. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
[TBL] [Abstract][Full Text] [Related]
26. Influence of HLA matching on survival in heart transplantation.
Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
[TBL] [Abstract][Full Text] [Related]
27. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
[TBL] [Abstract][Full Text] [Related]
28. Effects of early steroid withdrawal after heart transplantation.
Rosenbaum DH; Adams BC; Mitchell JD; Jessen ME; Paul MC; Kaiser PA; Pappas PA; Meyer DM; Wait MA; Drazner MH; Yancy CW; Ring WS; DiMaio JM
Ann Thorac Surg; 2006 Aug; 82(2):637-44; discussion 644. PubMed ID: 16863778
[TBL] [Abstract][Full Text] [Related]
29. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
30. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with long-term survival following cardiac transplantation.
Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
33. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation.
Park JW; Merz M; Braun P; Vermeltfoort M
J Heart Lung Transplant; 1996 Jun; 15(6):572-9. PubMed ID: 8803754
[TBL] [Abstract][Full Text] [Related]
34. Sensitisation and post-transplant course after the implantation of ventricular assist device.
Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
[TBL] [Abstract][Full Text] [Related]
35. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation.
Renlund DG; O'Connell JB; Gilbert EM; Watson FS; Bristow MR
J Heart Transplant; 1987; 6(2):71-8. PubMed ID: 3305832
[TBL] [Abstract][Full Text] [Related]
37. Influence of HLA matching and associated factors on aortic valve homograft function.
Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
[TBL] [Abstract][Full Text] [Related]
38. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
40. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation.
Harada H; Miura M; Ogawa Y; Seki T; Taniguchi A; Takenouchi T; Togashi M; Hirano T
Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
